Dr. Adams was appointed a director in June 2005 and joined IRIS as Corporate Vice President and Chief Technology Officer in April 2006 when the Company acquired Leucadia Technologies, a privately held medical-device company which he founded in 1998. Dr. Adams served as Chairman and Chief Executive Officer of Leucadia Technologies. In 1989 Dr. Adams founded Genta, Inc., a publicly held biotechnology company in the field of antisense technology, and served as its Chief Executive Officer until 1997. Dr. Adams founded Gen-Probe, Inc. in 1984 and served as its Chief Executive Officer and Chairman until 1989. Before founding Gen-Probe, Dr. Adams was CTO of Hybritech Inc. and has also held management positions at Technicon Instruments and the Hyland Division of Baxter. He served as a director of Biosite Diagnostics, Inc. from 1989 to 1998 and as a director of Invitrogen from 2000 to 2002. Dr. Adams currently serves as a director of La Jolla Pharmaceutical Co. and the privately held company, XiFin, Inc. Dr. Adams holds a Ph.D. in Biochemistry from the University of California, Riverside. |